Journal of Thoracic Oncology — Journal Profile & Submission Links
Elsevier Inc. · ISSN-L 1556-0864
Source-backed journal profile with OpenAlex metadata and links to official submission resources for Journal of Thoracic Oncology.
This page provides a source-backed journal profile and links to official submission resources. Journal instructions can change. Always verify article types, formatting, fees, ethics requirements, and submission rules on the official journal website before submitting.
Official links
- Journal homepage
- www.journals.elsevier.com/journal-of-thoracic-oncology
- Author guidelines
- www.sciencedirect.com/journal/journal-of-thoracic-oncology/p…
- Submission portal
- www.editorialmanager.com/jto/default.aspx
Catalog scope notes
Official Journal of the International Association for the Study of Lung Cancer Journal of Thoracic Oncology (JTO), the official journal of the International Association for the Study of Lung Cancer, is the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis, and treatment of all thoracic malignancies. JTO emphasizes a multidisciplinary approach and includes original research reviews and opinion pieces. The audience includes epidemiologists, medical oncologists, radiation oncologists, thoracic surgeons, pulmonologists, radiologists, pathologists, nuclear medicine physicians, and research scientists with a special interest in thoracic oncology. The journal is interested in receiving manuscripts dealing with epidemiology, prevention, screening, early detection, staging, cure, and treatment of thoracic malignancies. Submissions on tobacco control and cessation are of interest, particularly where there is direct relevance to lung cancer epidemiology and therapeutic outcomes. The Journal also welcomes submissions on pathologic and histologic classification and novel imaging and bronchoscopic approaches. Submissions regarding novel systemic therapies, particularly in the fields of biomarker targets, genomics, immunology, and cellular therapies are of interest. Novel radiotherapy and surgical techniques are of interest. Submission of randomized phase II and phase III trials, as well as meta analyses of individual participant data, are encouraged. Basic science studies must have direct clinical and translational relevance. Authors are also welcome to submit to the journal's open access companion title, JTO Clinical and Research Reports, which welcomes a range of manuscripts from subset analyses of published trials to high-quality case reports.
Catalog source: merged. This is not a copy of the publisher's author instructions.
Submission & timeline
- Submission portal
- www.editorialmanager.com/jto/default.aspx
- Average review time
- Information not currently available.
- Acceptance rate
- Information not currently available.
- Article types accepted
- Information not currently available.
- Publication frequency
- Information not currently available.
General pre-submission checks for medical manuscripts
Generic checklist only — not journal-specific requirements.
- Confirm scope fit and intended article type on the official journal site.
- Abstract structure matches the journal's current requirements.
- Ethics approval and trial registration statements are complete.
- Informed consent and patient privacy statements are in place.
- Reporting guideline compliance (e.g. CONSORT, STROBE, PRISMA) as applicable.
- Reference style and citation limits per official guidelines.
- Figures and tables meet resolution, labeling, and count limits.
- Cover letter addresses novelty, fit, and required declarations.
- Conflicts of interest statement included.
- Funding statement included.
- Data availability statement included when required.